US Stock MarketDetailed Quotes

TCBP TC BioPharm

Watchlist
  • 0.6500
  • +0.1810+38.59%
Close Dec 18 16:00 ET
  • 0.5700
  • -0.0800-12.31%
Pre 05:20 ET
5.34MMarket Cap0.00P/E (TTM)

TC BioPharm Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q4)Dec 31, 2021
(Q3)Sep 30, 2021
(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
30.60%-2.73M
17.27%-2.41M
31.04%-10.54M
-3.94M
-2.91M
-174.01%-15.29M
-62.62%-5.58M
-2.55M
-1.09M
49.00%-3.43M
Net income from continuing operations
-300.08%-1.99M
-423.20%-3.32M
-349.68%-5.91M
--992.89K
---634.91K
91.23%-1.31M
-126.00%-14.98M
---4.52M
---7.3M
3.83%-6.63M
Operating gains losses
--0
99.64%-11.45K
49.97%-7.97M
---5.08M
---3.17M
-475.26%-15.94M
224,465.20%4.25M
--271.05K
--3.97M
-97.40%1.89K
Depreciation and amortization
-24.88%120.58K
-29.81%127.02K
-17.75%633.01K
--160.52K
--180.97K
-24.92%769.6K
-4.66%1.03M
--250.35K
--249.31K
18.88%1.08M
Other non cash items
----
----
-89.40%717.41K
--465.29K
--231.54K
96.85%6.77M
1,081.49%3.44M
--1.92M
--1.15M
14.80%291.03K
Change In working capital
-107.57%-990.84K
-96.11%13.13K
122.96%1.54M
---477.36K
--337.21K
-2,789.09%-6.7M
-402.61%-232.08K
---410.55K
---270.81K
104.23%76.69K
-Change in receivables
64.74%-105.79K
72.31%-110.74K
316.24%676.41K
---300K
---400K
47.13%-312.8K
-134.22%-591.62K
---447.53K
---244.18K
569.96%1.73M
-Change in prepaid assets
1,716.03%379.62K
-61.73%127.24K
-3,300.45%-1.28M
---23.49K
--332.51K
---37.5K
----
----
----
----
-Change in payables and accrued expense
-1,006.56%-1.24M
-95.17%21.61K
216.88%2.27M
---112.22K
--447.42K
-183.16%-1.94M
616.02%2.34M
--531.65K
--468.04K
884.71%326.56K
-Change in other current assets
13.35%51.68K
4.00%48.06K
-3.60%189.51K
--45.6K
--46.21K
--196.58K
----
----
----
----
-Change in other current liabilities
14.49%-74.6K
17.88%-73.03K
57.53%-323.71K
---87.24K
---88.93K
---762.15K
----
----
----
----
-Change in other working capital
----
----
----
----
----
-94.30%-3.84M
0.00%-1.98M
---494.67K
---494.66K
2.56%-1.98M
Cash from discontinued investing activities
Operating cash flow
30.60%-2.73M
17.27%-2.41M
31.04%-10.54M
---3.94M
---2.91M
-174.01%-15.29M
-62.62%-5.58M
---2.55M
---1.09M
49.00%-3.43M
Investing cash flow
Cash flow from continuing investing activities
58.01%-30.06K
96.13%-5.62K
32.69%-208.79K
-71.59K
-145.23K
-116.58%-310.2K
30.13%-143.22K
-52.04K
-30.27K
90.67%-204.99K
Net PPE purchase and sale
46.09%-20.85K
--0
40.58%-110.35K
---38.68K
---120.18K
-827.03%-185.71K
42.60%-20.03K
---8.75K
---9.34K
98.28%-34.9K
Net intangibles purchase and sale
72.02%-9.21K
77.57%-5.62K
20.93%-98.44K
---32.91K
---25.05K
-1.05%-124.49K
27.57%-123.19K
---43.29K
---20.94K
-0.02%-170.09K
Cash from discontinued investing activities
Investing cash flow
58.01%-30.06K
96.13%-5.62K
32.69%-208.79K
---71.59K
---145.23K
-116.58%-310.2K
30.13%-143.22K
---52.04K
---30.27K
90.67%-204.99K
Financing cash flow
Cash flow from continuing financing activities
1,154.62%2.79M
-76.42%932.56K
-54.32%8.52M
222.07K
3.95M
185.87%18.65M
90.22%6.53M
2.61M
2.36M
4.78%3.43M
Net issuance payments of debt
----
----
--0
----
----
-141.75%-2.61M
1,607.73%6.26M
--2.61M
--2.36M
-406.39%-415.27K
Net common stock issuance
--0
-98.63%19.77K
24.24%4.19M
--2.25K
--1.44M
1,081.97%3.37M
-92.69%285.11K
--1
--0
24.24%3.9M
Proceeds from stock option exercised by employees
1,167.44%2.79M
-63.09%986.77K
-72.74%5.13M
--219.83K
--2.67M
--18.81M
--0
----
----
--0
Net other financing activities
--0
53.46%-73.98K
12.64%-793.75K
--0
---158.97K
-4,193.96%-908.6K
60.28%-21.16K
--0
--0
---53.27K
Cash from discontinued financing activities
Financing cash flow
1,154.62%2.79M
-76.42%932.56K
-54.32%8.52M
--222.07K
--3.95M
185.87%18.65M
90.22%6.53M
--2.61M
--2.36M
4.78%3.43M
Net cash flow
Beginning cash position
-82.81%980.96K
-48.78%2.46M
206.89%4.81M
--5.71M
--4.81M
109.45%1.57M
-21.80%748.02K
--1.55M
--287.99K
-85.66%956.5K
Current changes in cash
100.62%23.37K
-265.04%-1.48M
-173.21%-2.23M
---3.79M
--897.76K
280.92%3.05M
487.67%800.89K
--15.62K
--1.24M
96.35%-206.59K
Effect of exchange rate changes
----
----
-158.83%-112.17K
----
----
972.22%190.65K
1,040.30%17.78K
--296
--18.76K
96.95%-1.89K
End cash Position
-47.65%1M
-82.81%980.96K
-48.78%2.46M
--1.92M
--5.71M
206.89%4.81M
109.45%1.57M
--1.57M
--1.55M
-21.80%748.02K
Free cash flow
31.09%-2.76M
21.01%-2.41M
31.32%-10.75M
---4.01M
---3.06M
-173.53%-15.66M
-57.40%-5.72M
---2.6M
---1.12M
59.26%-3.64M
Currency Unit
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
GBP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion with Explanatory Notes
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q4)Dec 31, 2021(Q3)Sep 30, 2021(FY)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 30.60%-2.73M17.27%-2.41M31.04%-10.54M-3.94M-2.91M-174.01%-15.29M-62.62%-5.58M-2.55M-1.09M49.00%-3.43M
Net income from continuing operations -300.08%-1.99M-423.20%-3.32M-349.68%-5.91M--992.89K---634.91K91.23%-1.31M-126.00%-14.98M---4.52M---7.3M3.83%-6.63M
Operating gains losses --099.64%-11.45K49.97%-7.97M---5.08M---3.17M-475.26%-15.94M224,465.20%4.25M--271.05K--3.97M-97.40%1.89K
Depreciation and amortization -24.88%120.58K-29.81%127.02K-17.75%633.01K--160.52K--180.97K-24.92%769.6K-4.66%1.03M--250.35K--249.31K18.88%1.08M
Other non cash items ---------89.40%717.41K--465.29K--231.54K96.85%6.77M1,081.49%3.44M--1.92M--1.15M14.80%291.03K
Change In working capital -107.57%-990.84K-96.11%13.13K122.96%1.54M---477.36K--337.21K-2,789.09%-6.7M-402.61%-232.08K---410.55K---270.81K104.23%76.69K
-Change in receivables 64.74%-105.79K72.31%-110.74K316.24%676.41K---300K---400K47.13%-312.8K-134.22%-591.62K---447.53K---244.18K569.96%1.73M
-Change in prepaid assets 1,716.03%379.62K-61.73%127.24K-3,300.45%-1.28M---23.49K--332.51K---37.5K----------------
-Change in payables and accrued expense -1,006.56%-1.24M-95.17%21.61K216.88%2.27M---112.22K--447.42K-183.16%-1.94M616.02%2.34M--531.65K--468.04K884.71%326.56K
-Change in other current assets 13.35%51.68K4.00%48.06K-3.60%189.51K--45.6K--46.21K--196.58K----------------
-Change in other current liabilities 14.49%-74.6K17.88%-73.03K57.53%-323.71K---87.24K---88.93K---762.15K----------------
-Change in other working capital ---------------------94.30%-3.84M0.00%-1.98M---494.67K---494.66K2.56%-1.98M
Cash from discontinued investing activities
Operating cash flow 30.60%-2.73M17.27%-2.41M31.04%-10.54M---3.94M---2.91M-174.01%-15.29M-62.62%-5.58M---2.55M---1.09M49.00%-3.43M
Investing cash flow
Cash flow from continuing investing activities 58.01%-30.06K96.13%-5.62K32.69%-208.79K-71.59K-145.23K-116.58%-310.2K30.13%-143.22K-52.04K-30.27K90.67%-204.99K
Net PPE purchase and sale 46.09%-20.85K--040.58%-110.35K---38.68K---120.18K-827.03%-185.71K42.60%-20.03K---8.75K---9.34K98.28%-34.9K
Net intangibles purchase and sale 72.02%-9.21K77.57%-5.62K20.93%-98.44K---32.91K---25.05K-1.05%-124.49K27.57%-123.19K---43.29K---20.94K-0.02%-170.09K
Cash from discontinued investing activities
Investing cash flow 58.01%-30.06K96.13%-5.62K32.69%-208.79K---71.59K---145.23K-116.58%-310.2K30.13%-143.22K---52.04K---30.27K90.67%-204.99K
Financing cash flow
Cash flow from continuing financing activities 1,154.62%2.79M-76.42%932.56K-54.32%8.52M222.07K3.95M185.87%18.65M90.22%6.53M2.61M2.36M4.78%3.43M
Net issuance payments of debt ----------0---------141.75%-2.61M1,607.73%6.26M--2.61M--2.36M-406.39%-415.27K
Net common stock issuance --0-98.63%19.77K24.24%4.19M--2.25K--1.44M1,081.97%3.37M-92.69%285.11K--1--024.24%3.9M
Proceeds from stock option exercised by employees 1,167.44%2.79M-63.09%986.77K-72.74%5.13M--219.83K--2.67M--18.81M--0----------0
Net other financing activities --053.46%-73.98K12.64%-793.75K--0---158.97K-4,193.96%-908.6K60.28%-21.16K--0--0---53.27K
Cash from discontinued financing activities
Financing cash flow 1,154.62%2.79M-76.42%932.56K-54.32%8.52M--222.07K--3.95M185.87%18.65M90.22%6.53M--2.61M--2.36M4.78%3.43M
Net cash flow
Beginning cash position -82.81%980.96K-48.78%2.46M206.89%4.81M--5.71M--4.81M109.45%1.57M-21.80%748.02K--1.55M--287.99K-85.66%956.5K
Current changes in cash 100.62%23.37K-265.04%-1.48M-173.21%-2.23M---3.79M--897.76K280.92%3.05M487.67%800.89K--15.62K--1.24M96.35%-206.59K
Effect of exchange rate changes ---------158.83%-112.17K--------972.22%190.65K1,040.30%17.78K--296--18.76K96.95%-1.89K
End cash Position -47.65%1M-82.81%980.96K-48.78%2.46M--1.92M--5.71M206.89%4.81M109.45%1.57M--1.57M--1.55M-21.80%748.02K
Free cash flow 31.09%-2.76M21.01%-2.41M31.32%-10.75M---4.01M---3.06M-173.53%-15.66M-57.40%-5.72M---2.6M---1.12M59.26%-3.64M
Currency Unit GBPGBPGBPGBPGBPGBPGBPGBPGBPGBP
Audit Opinions ----Unqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory NotesUnqualified Opinion with Explanatory Notes----Unqualified Opinion with Explanatory Notes
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.